<DOC>
	<DOCNO>NCT01121809</DOCNO>
	<brief_summary>Hypothesis : intracellular concentration raltegravir ( RAL ) etravirine ( ETV ) administrate 800 400 mg day , respectively , similar obtain standard dos 400 200 mg/12h , respectively . Objective : To analyze plasma intracellular concentration RAL ETV administrate 800 400 mg daily respectively compare standard dos 400 200 mg/12h , respectively , support daily administration .</brief_summary>
	<brief_title>Plasma Intracellular Concentrations Raltegravir Etravirine Administered Once Daily</brief_title>
	<detailed_description>Objective : To analyze plasma intracellular concentration RAL ETV administrate 800 400 mg daily respectively compare standard dos 400 200 mg/12h , respectively , support daily administration . Method : Phase IV , prospective , open label clinical trial plan duration 24 week 16 patient Hospitales Universitarios Virgen del Roc√≠o enrol . A 12 hour pharmacokinetic profile ( immediately 1 , 2 , 3 , 4 , 6 , 8 , 10 12 h ) obtain supervise drug intake take RAL ETV bid . Afterwards , patient take RAL ETV day 7 - 10 day . Subsequently , new pharmacokinetic profile ( predose 1 , 2 , 3 , 4 , 6 , 8 , 10 , 12 , 16 , 20 24 h supervised drug intake ) obtain .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Etravirine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Adult HIV1infected patient take raltegravir etravirinebased antiretroviral regimen Pregnancy Concomitant use drug potential interaction raltegravir etravirine pharmacokinetics Cirrhosis clinical analytic data liver failure . Clinical history suggest malabsorption presence diarrhea ( &gt; 3 stool / day ) could interfere absorption study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Raltegravir</keyword>
	<keyword>etravirine</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>intracellular</keyword>
</DOC>